Swiss drugmaker Roche on Thursday lifted its full-year guidance even after reporting nine-month sales that were below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results